0001209191-20-039146.txt : 20200626
0001209191-20-039146.hdr.sgml : 20200626
20200626174933
ACCESSION NUMBER: 0001209191-20-039146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200625
FILED AS OF DATE: 20200626
DATE AS OF CHANGE: 20200626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Giordano Michael F
CENTRAL INDEX KEY: 0001733915
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 20995336
MAIL ADDRESS:
STREET 1: C/O EPIZYME, INC.
STREET 2: 400 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RAPT Therapeutics, Inc.
CENTRAL INDEX KEY: 0001673772
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473313701
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 489-9000
MAIL ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLX Bio, Inc.
DATE OF NAME CHANGE: 20160504
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-25
0
0001673772
RAPT Therapeutics, Inc.
RAPT
0001733915
Giordano Michael F
C/O RAPT THERAPEUTICS, INC.
561 ECCLES AVENUE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2020-06-25
4
M
0
10069
6.18
A
10069
D
Common Stock
2020-06-25
4
M
0
8944
12.00
A
8944
D
Common Stock
2020-06-25
4
S
0
19013
33.37
D
0
D
Stock Option (right to buy)
6.18
2020-06-25
4
M
0
10069
0.00
D
2028-03-27
Common Stock
10069
6597
D
Stock Option (right to buy)
12.00
2020-06-25
4
M
0
8944
0.00
D
2029-10-29
Common Stock
8944
6390
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $34.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The shares subject to the option vest in 48 equal monthly installments from the vesting commencement date.
The shares subject to the option vest in 12 equal monthly installments from the vesting commencement date.
/s/ Karen C. Lam, attorney-in-fact for Michael F. Giordano
2020-06-26